Virus-modified homologus tumor-cell extract in the treatment of vulvar carcinoma

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES

1972 • 2,462 citations

Measurement of Delayed Skin-Test Responses

1975 • 516 citations

A Simplified Procedure for Titrating Hemagglutinating Capacity of Influenza-Virus and the Corresponding Antibody

1944 • 423 citations

Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A‐strain specificity while infected cells confer cross‐reactive cytotoxicity

1977 • 150 citations

Carcinoma of the vulva

1970 • 145 citations

Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer

1972 • 137 citations

Viruses as immunological adjuvants in cancer

1974 • 68 citations

Viral oncolysate in the management of malignant melanoma. II. Clinical studies

1977 • 63 citations

A new approach in specific, active immunotherapy

1977 • 63 citations

Back to the drawing board—the need for more realistic model systems for immunotherapy

1977 • 48 citations

Augmented Immunogenicity of Tumor Cell Homogenates Infected with Influenza Virus

1974 • 46 citations

[Carcinoma of the vulva].

1949 • 46 citations

Virus Carrier State Suppresses Tumorigenicity of Tumor Cells in Athymic (Nude) Mice

1979 • 30 citations

IMMUNOTHERAPY OF OSTEOSARCOMA PATIENTS WITH VIRUS‐MODIFIED TUMOR CELLS*

1976 • 21 citations

Melanoma skin test antigens of improved sensitivity prepared from vesicular stomatitis virus-infected tumor cells

1978 • 18 citations

Association of carcinoembryonic antigen (CEA) and influenza antigen

1978 • 3 citations